July 5, 2011 The PRO Consortium: An FDA-Endorsed Process for PRO Instrument Development in GI Disorders and Beyond
March 15, 2011 Second Annual Patient-Reported Outcome Consortium Workshop March 15, 2011 Sheraton Silver Spring Hotel 8777 Georgia Avenue – Silver Spring, MD 20910 SPONSORED BY: Critical Path Instit
March 11, 2011 Mixing Modes of Patient-Reported Outcomes Data Collection in Clinical Trials: Recommendations
February 8, 2011 Development and Evaluation of a Genomic Signature for the Prediction and Mechanistic Assessment of Nongenotoxic Hepatocarcinogens in the Rat
January 12, 2011 Patient Self-report for Evaluating Mild Cognitive Impairment and Prodromal Alzheimer’s Disease
October 5, 2010 Renal Biomarker Qualification Submission: A Dialog Between the FDA-EMEA and Predictive Safety Testing Consortium
October 5, 2010 Urinary Clusterin, Cystatin C, [beta]2-Microglobulin and Total Protein as Markers to Detect Drug-Induced Kidney Injury
